Abstract
Persistent activation of Gαi/o-coupled receptors results in an enhanced responsiveness of drug-stimulated adenylate cyclase activity through an unknown mechanism. This agonist-induced heterologous sensitization of drug-stimulated cyclic AMP accumulation has been proposed to be a mechanism by which cells adapt to prolonged Gαi/o activation. Heterologous sensitization was examined in human embryonic kidney 293 cells stably expressing D2Ldopamine receptors in combination with recombinant isoforms of adenylate cyclase. The ability of each isoform to be differentially regulated by G protein subunits and other signaling intermediates allowed us to identify potential mechanisms that are involved in heterologous sensitization of adenylate cyclase. We now report that both short- and long-term activation of D2L dopamine receptors resulted in a marked degree of sensitization of ACI, ACII, ACV, and ACIX, but not ACVIII. The effects of agonist treatment on ACI, ACII, and ACVIII appeared to be dependent upon the ability of these adenylate cyclase isoforms to synergistically respond to selective activators in the presence of activated Gαs. Sensitization of ACV was characterized by enhanced cyclic AMP accumulation following Gαs or forskolin stimulation. Furthermore, agonist pretreatment enhanced the basal levels of cyclic AMP accumulation in ACV/D2L cells, an effect that was not observed with the other adenylate cyclase isoforms. ACIX, which has no known activators other than Gαs, showed robust agonist-induced sensitization of isoproterenol-stimulated cyclic AMP accumulation. In summary, heterologous sensitization appeared to be related to the ability of each adenylate cyclase isoform to be modulated by Gαs.
Footnotes
-
Send reprint requests to: Val J. Watts, Ph.D., Purdue University, MCMP 1333, RHPH 224A, West Lafayette, IN 47907. E-mail: wattsv{at}pharmacy.purdue.edu
-
This work was supported by U.S. Public Health Service Grant MH60397, a National Alliance for Research on Schizophrenia and Depression Young Investigator Award, and Purdue University.
- Abbreviations:
- ACI-IX
- type I-IX adenylate cyclase
- PMA
- phorbol-12-myristate-13-acetate
- HEK
- human embryonic kidney
- IBMX
- isobutylmethylxanthine
- Received October 6, 2000.
- Accepted March 7, 2001.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|